Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
Shinohara, Yukito, Prof, Katayama, Yasuo, Prof, Uchiyama, Shinichiro, Prof, Yamaguchi, Takenori, MD, Handa, Shunnosuke, Prof, Matsuoka, Kempei, MD, Ohashi, Yasuo, Prof, Tanahashi, Norio, Prof, Yamamoto, Hiroko, MD, Genka, Chokoh, MD, Kitagawa, Yasuhisa, Prof, Kusuoka, Hideo, MD, Nishimaru, Katsuya, MD, Tsushima, Motoo, MD, Koretsune, Yukihiro, MD, Sawada, Tohru, MD, Hamada, Chikuma, Prof
Published in Lancet neurology (01.10.2010)
Published in Lancet neurology (01.10.2010)
Get full text
Journal Article
Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5)
Yamaguchi, Takenori, MD, Awano, Hideto, MS, Matsuda, Hiroaki, MPH, Tanahashi, Norio, MD
Published in Journal of stroke and cerebrovascular diseases (01.04.2017)
Published in Journal of stroke and cerebrovascular diseases (01.04.2017)
Get full text
Journal Article
Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
Aguilar, Maria I., MD, Hart, Robert G., MD, Kase, Carlos S., MD, Freeman, William D., MD, Hoeben, Barbara J., PharmD, USAF, García, Rosa C., RPh, Ansell, Jack E., MD, Mayer, Stephan A., MD, Norrving, Bo, MD, PhD, FESC, Rosand, Jonathan, MD, MSc, Steiner, Thorsten, MD, Wijdicks, Eelco F.M., MD, Yamaguchi, Takenori, MD, Yasaka, Masahiro, MD
Published in Mayo Clinic proceedings (2007)
Published in Mayo Clinic proceedings (2007)
Get full text
Journal Article
Guidelines for the Intravenous Application of Recombinant Tissue-type Plasminogen Activator (Alteplase), the Second Edition, October 2012: A Guideline From the Japan Stroke Society
Minematsu, Kazuo, MD, PhD, Toyoda, Kazunori, MD, PhD, Hirano, Teruyuki, MD, PhD, Kimura, Kazumi, MD, PhD, Kondo, Rei, MD, PhD, Mori, Etsuro, MD, PhD, Nakagawara, Jyoji, MD, PhD, Sakai, Nobuyuki, MD, DMSc, Shiokawa, Yoshiaki, MD, PhD, Tanahashi, Norio, MD, PhD, Yasaka, Masahiro, MD, PhD, Katayama, Yasuo, MD, PhD, Miyamoto, Susumu, MD, PhD, Ogawa, Akira, MD, PhD, Sasaki, Makoto, MD, PhD, Suga, Sadao, MD, PhD, Yamaguchi, Takenori, MD, PhD
Published in Journal of stroke and cerebrovascular diseases (01.07.2013)
Published in Journal of stroke and cerebrovascular diseases (01.07.2013)
Get full text
Journal Article
Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study
Yasaka, Masahiro, MD, Minematsu, Kazuo, MD, Toyoda, Kazunori, MD, Yamagami, Hiroshi, MD, Yoshimura, Shinichi, MD, Nagao, Takehiko, MD, Mori, Etsuro, MD, Hirano, Teruyuki, MD, Hamasaki, Toshimitsu, PhD, Yamaguchi, Takenori, MD
Published in Journal of stroke and cerebrovascular diseases (01.06.2016)
Published in Journal of stroke and cerebrovascular diseases (01.06.2016)
Get full text
Journal Article
Prognostic Significance of Smoking in Patients With Acute Ischemic Stroke Within 3 Months of Onset
Kumagai, Naoko, MS, Origasa, Hideki, PhD, Nagao, Takehiko, MD, PhD, Takekawa, Hidehiro, MD, PhD, Okuhara, Yoshiyasu, PhD, Yamaguchi, Takenori, MD, PhD
Published in Journal of stroke and cerebrovascular diseases (01.08.2013)
Published in Journal of stroke and cerebrovascular diseases (01.08.2013)
Get full text
Journal Article
Factors Predicting Outcome in Stroke Patients Treated With 0.6 mg/kg Alteplase: Evidence From the Japan Alteplase Clinical Trial (J-ACT)
Mori, Etsuro, MD, Minematsu, Kazuo, MD, Nakagawara, Jyoji, MD, Yamaguchi, Takenori, MD
Published in Journal of stroke and cerebrovascular diseases (01.11.2011)
Published in Journal of stroke and cerebrovascular diseases (01.11.2011)
Get full text
Journal Article